Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 20, 2020OncogeneOpen Access

MiR-450a-5p strengthens the drug sensitivity of gefitinib in glioma chemotherapy via regulating autophagy by targeting EGFR

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYu LiuNeijiang Normal UniversityLYLiang YangNingbo UniversityFLFan LiaoCentral South University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2020) studied this question.

synapsesocial.com/papers/6a9fa41bf4a75fa1ef44a5dahttps://doi.org/10.1038/s41388-020-01422-9
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation2015 · 54 citations
  2. 2mTOR Pathways in Cancer and Autophagy2018 · 306 citations
  3. 3microRNAs Make the Call in Cancer Personalized Medicine2017 · 89 citations
  4. 4MiR-136 modulates glioma cell sensitivity to temozolomide by targeting astrocyte elevated gene-12014 · 50 citations
  5. 5Plasma microRNA alterations between EGFR-activating mutational NSCLC patients with and without primary resistance to TKI2017 · 47 citations